Biotechnological Ricin for Immunological Studies from Germany
Recombinant ricin toxin produced through biotech processes for studying immune responses and antibody production. Classified in HTS 3002.49.0010 as a modified toxin for diagnostic and therapeutic research. Used in labs to develop countermeasures against bioterrorism agents.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include biotech origin certificate and sequence data to justify classification under modified immunological products
• Use IATA-compliant packaging for air import; verify receiver's BSL-3 lab status to prevent denial